Drugs / Zinc - Laboratoire Aguettant, the others generic
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00515736 | Jan 2003 → Dec 2005 | subarachnoid hemorrhage | Centre Hospitalier Universitaire Vaudois | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zinc - Laboratoire Aguettant, the others generic | “Zinc - Laboratoire Aguettant, the others generic” NCT00515736 ↗ |
| Known as | Zinc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00515736 ↗ |
| Modality | Other / unclassified | “combination of AOX micronutrient supplements” NCT00515736 ↗ |
| Route | Intravenous | “The intervention was intravenous supplements for 5 days” PMID 18687132 ↗ Aug 2008 |